83 related articles for article (PubMed ID: 840335)
1. The use of serial determination of blood serum glycoproteins for indirect evidence of the sensitivity and resistance of malignant tumor cells to clinical chemotherapy.
Kafka V; Musil J
Neoplasma; 1977; 24(1):101-7. PubMed ID: 840335
[TBL] [Abstract][Full Text] [Related]
2. [Serum glycoproteins in patients with malignant tumor with special reference to the change of alpha--acid glycoprotein during cancer chemotherapy].
Kimura I; Onoshi T; Kunimasa I; Takano J
Gan No Rinsho; 1970 Aug; 16(8):809-14. PubMed ID: 5465968
[No Abstract] [Full Text] [Related]
3. Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors.
Tatsumura T; Sato H; Mori A; Komori Y; Yamamoto K; Fukatani G; Kuno S
Cancer Res; 1977 Nov; 37(11):4101-3. PubMed ID: 908042
[TBL] [Abstract][Full Text] [Related]
4. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
5. Importance of glycoproteins in human cancer.
Patel PS; Raval GN; Rawal RM; Patel MM; Balar DB; Patel DD
Indian J Biochem Biophys; 1997; 34(1-2):226-33. PubMed ID: 9343956
[TBL] [Abstract][Full Text] [Related]
6. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
Sládek NE; Kollander R; Sreerama L; Kiang DT
Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of glycosyltransferases and related glycoproteins as indicators of cancer: biological and clinical implications.
Weiser MM; Wilson JR
Crit Rev Clin Lab Sci; 1981; 14(3):189-239. PubMed ID: 6456133
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of water soluble and lipid soluble sialic acid levels as tumor markers.
Shamberger RJ
Anticancer Res; 1986; 6(4):717-20. PubMed ID: 3752951
[TBL] [Abstract][Full Text] [Related]
9. [Sialic acid in the serum--an indicator for malignant growth?].
Schulze G
Arch Geschwulstforsch; 1990; 60(1):19-24. PubMed ID: 2310297
[TBL] [Abstract][Full Text] [Related]
10. [Change in levels of specific terminal sugar residues of glycoproteins in sera of patients with malignant tumor].
Nishida K; Nagamura Y; Ohta Y; Ito M; Ishiguro I
Rinsho Byori; 1993 Aug; 41(8):937-9. PubMed ID: 8371510
[TBL] [Abstract][Full Text] [Related]
11. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
[TBL] [Abstract][Full Text] [Related]
12. Plasma sialic acid alterations in neoplastic diseases.
Dwivedi C; Dixit M; Kumar SS; Reddy H; Semenya KA; Hardy RE
J Med; 1987; 18(5-6):323-32. PubMed ID: 3505259
[TBL] [Abstract][Full Text] [Related]
13. [The determination of sialic acid in cancer patients].
Correale M; Abbate I; Gargano G; Catino A; Musci MD; Dragone CD; De Lena M
Minerva Med; 1992; 83(7-8):427-31. PubMed ID: 1522966
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricaemia as an index of the response to chemotherapy in solid tumors.
Wiktor-Jedrzejczak W; Siekierzynski M; Piechota W
Neoplasma; 1977; 24(4):457-60. PubMed ID: 904751
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in pediatric malignancies.
Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
[TBL] [Abstract][Full Text] [Related]
16. Lipid associated sialic acid in plasma in patients with advanced carcinoma of the ovaries.
Vardi JR; Tadros GH; Malhotra C; Charney T; Shebes M; Foemmel R
Surg Gynecol Obstet; 1989 Apr; 168(4):296-301. PubMed ID: 2928903
[TBL] [Abstract][Full Text] [Related]
17. [Circulating lipid-bound sialic acid levels in patients with malignant tumors].
Bassalyk LS; Novikov AM; Sokolova VD; Sorokin EN
Vopr Med Khim; 1984; 30(3):124-7. PubMed ID: 6474937
[TBL] [Abstract][Full Text] [Related]
18. [Serum glycoproteins and mucoproteins in leukemia and malignant tumors].
Itoga T; Oka S
Rinsho Byori; 1970 Mar; 18(3):169-74. PubMed ID: 5462825
[No Abstract] [Full Text] [Related]
19. Evaluation of glycoproteins as prognosticators in head and neck malignancy.
Bathi RJ; Nandimath K; Kannan N; Shetty P
Indian J Dent Res; 2001; 12(2):93-9. PubMed ID: 11665403
[TBL] [Abstract][Full Text] [Related]
20. [The clinical significance of sialic acid in the serum in benign and malignant disease].
Henn KH; Gressner AM
J Clin Chem Clin Biochem; 1987 Jul; 25(7):423-30. PubMed ID: 3655663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
